retatrutide and breastfeeding What are the considerations for using (glucagon-like peptide-1 receptor agonist) in women with type 2 diabetes or obesity? Retatrutide—A Game Changer in Obesity

Contact your doctor if you experience new or worsening cognitive symptoms after starting GLP-1 therapy, especially if accompanied by severe nausea, dehydration, or signs of hypoglycemia

The lifestyle intervention component is built on the U.S

A systematic review of GLP-1 RA use in Alzheimers disease and related outcomes found that while preclinical studies (in animals) are strongly positive, human clinical data are limited

doi: 10.1007/s11695-016-2314-x 58 VigneshwaranBWahalAAggarwalSPriyadarshiniPBhattacharjeeHKhadgawatRet al

Allison Debussy, an APRN with Baptist Health Weight Loss Center, shed some light on these increasingly popular medications